Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone

NCT01998217 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT01998217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01998217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone
Lead sponsor
Changhai Hospital
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2012
Completion date
December 31, 2013
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic stone disease